HNSCC or control patient PB CD71 positivity (%) on T lymphocytes (CD3-positive cells) or monocyte 24 hours in vitro LPS-stimulated IL-6 secretion (pg/ml). The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.